Frontlight ResearchEarly access
Trial site
Centre Hospitalier de Niort
- 11running trials
- 2closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- ANCA-associated vasculitis2 trials
- Atopic dermatitis (eczema)2 trials
- Follicular lymphoma2 trials
- Burkitt lymphoma1 trial
- Colorectal cancer1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Hepatitis C1 trial
- HIV1 trial
- Hodgkin lymphoma1 trial
- Mantle cell lymphoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Recruiting6 trials
- Active, not recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris2 trials
- Hospices Civils de Lyon2 trials
- Almirall, S.A.1 trial
- Assistance Publique Hopitaux De Paris1 trial
- Centre Hospitalier Universitaire De Nantes1 trial
- and 6 more
Running trials
Not yet recruiting
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Not yet recruiting
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
Recruiting
Active, not recruiting
Recruiting
Recruiting
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
Active, not recruiting
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
Recruiting
Recruiting
Completed
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- ANCA-associated vasculitis1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Burkitt lymphoma1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Follicular lymphoma1 recruiting
- Hepatitis C1 recruiting
- HIV1 recruiting
- Hodgkin lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Multiple myeloma1 recruiting
- Rheumatoid arthritis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026